Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settings

Dean B. Everett, Kathy Baisley, John Changalucha, Andrew Vallely, Deborah Watson-Jones, Claire Cook, Louise Knight, David A. Ross, Kokugonza Mugeye, Sheena Mccormack, Charles J. Lacey, Ute Jentsch, Richard J. Hayes

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


The suitability and accuracy of using simple human immunodeficiency virus (HIV) rapid (SR) tests in community-based clinics in northwest Tanzania were determined to assess eligibility for participation in clinical trials. The HIV rapid and ELISA test results for 789 women aged 16 to 54 who were screened for two clinical trials of HIV prevention were compared. Women were offered voluntary HIV counseling and testing (VCT) at screening; those who accepted were tested with the Abbott Determine and Trinity Biotech Capillus SR tests in parallel. The results were confirmed by two parallel HIV enzyme-linked immunosorbent assay (ELISA) tests (Abbott Murex HIV Ag/Ab combination and Vironostika Uniform II HIV Ag/Ab) to determine eligibility. Positive samples for any of the four assays were confirmed by a line immunoassay and p24 testing. The parallel SR tests had high concordance (96.2%) with the parallel ELISA algorithm. The sensitivities of the SR tests were 98.6% for Capillus (95% confidence interval [CI], 95.1 to 99.8%), 99.3% for Determine (95% CI, 96.2 to 100%), and 98.6% for the parallel SR (95% CI, 95.1 to 99.8%). The specificities were 99.7% for Capillus (95% CI, 98.9 to 100%), 99.7% for Determine (95% CI, 98.9 to 100%), and 100% for the parallel SR (95% CI, 99.4 to 100%). SR tests are suitable for use in community-based clinical research settings to assess eligibility both for trial participation and for the provision of on-site VCT services.

Original languageBritish English
Pages (from-to)1058-1062
Number of pages5
JournalJournal of Clinical Microbiology
Issue number4
StatePublished - Apr 2009


Dive into the research topics of 'Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settings'. Together they form a unique fingerprint.

Cite this